Watch: The Feds Reexamine Covid Protocols. Here’s Why You Should Care.
麻豆女优 Health News’ C茅line Gounder explains the “five-day rule” on covid safety, how guidelines and testing have evolved, and how best to protect yourself and others.
Watch: Older Americans Say They Feel Stuck in Medicare Advantage Plans
You鈥檝e probably seen advertising about Medicare Advantage plans. 麻豆女优 Health News’ Sarah Jane Tribble explains the pros and cons of this insurance option as enrollment in these plans increases.
鈥楢GGA鈥 Inventor Testifies His Dental Device Was Not Meant for TMJ or Sleep Apnea
The FDA and Department of Justice are investigating the Anterior Growth Guidance Appliance, or 鈥淎GGA.鈥 TMJ and sleep apnea patients have filed lawsuits alleging the device harmed them. Its inventor now says the AGGA was never meant for these ailments.
鈥楿ntil It Is Fixed鈥: Congress Ramps Up Action on Social Security Clawbacks
Sen. Ron Wyden (D-Ore.), chair of the Senate Finance Committee, vowed to meet monthly with Social Security officials until the problems surrounding overpayment demands are fixed.
Social Security Clawbacks Hit a Million More People Than Agency Chief Told Congress
More than 2 million people a year have been sent notices that Social Security overpaid them and demanding they repay the money. That鈥檚 twice as many as the head of Social Security disclosed at a congressional hearing in October.
麻豆女优 Health News editor-at-large for public health C茅line Gounder discusses how families of transgender youth are uprooting their lives due to anti-trans policies and their ripple effects.
Watch: Thinking Big in Public Health, Inspired by the End of Smallpox
A conversation about how the lessons from the victory over smallpox could be applied to public health challenges today.
Watch: In Emergencies, First Comes the Ambulance. Then Comes the Bill.
This installment of InvestigateTV and 麻豆女优 Health News’ 鈥淐ostly Care鈥 series delves into the lack of cost protections for patients who find themselves on the hook for an emergency ground ambulance ride.
How the Texas Trial Changed the Story of Abortion Rights in America
Stark, plaintive testimony from women denied abortion care represents the start of 鈥渢he 50-year fight to get rid of Dobbs,鈥 one historian says.
Watch: Payback for the Opioid Crisis: How Did the Sackler Family Skirt Liability?
麻豆女优 Health News senior correspondent Aneri Pattani appeared on PBS NewsHour to discuss the ruling surrounding drugmaker Purdue Pharma’s role in the opioid crisis and her reporting into the ongoing distribution of opioid settlement funds.
Watch: 5th Circuit Judges Question Two-Decade-Old Approval of Abortion Pill
The 5th Circuit Court of Appeals in New Orleans heard oral arguments Wednesday in a case brought by conservative Christian abortion opponents seeking to revoke FDA approval of mifepristone, a medication used in more than half of abortions in the U.S.
After Idaho鈥檚 Strict Abortion Ban, OB-GYNs Stage a Quick Exodus
At least two Idaho hospitals are ending labor and delivery services, with one citing the state鈥檚 鈥渓egal and political climate鈥 and noting that 鈥渞ecruiting replacements will be extraordinarily difficult鈥 as doctors leave.
Watch: Rulings on Abortion Pill Have Far-Reaching Repercussions
Sarah Varney, a senior correspondent for KHN, joins Ali Rogin of PBS NewsHour to discuss the ruling by a federal judge in Texas that threatens nationwide access to the widely used abortion drug mifepristone, and a separate ruling in Washington state that reached the opposite conclusion.
Sen. Sanders Shows Fire, but Seeks Modest Goals, in His Debut Drug Hearing as Health Chair
The Vermont independent and former presidential candidate was all fire and brimstone at his first hearing on drug prices as head of the Senate HELP Committee. He also pursued a more modest goal of covid vaccine price reductions. It isn鈥檛 clear whether Sanders will succeed in even that, but he has put affordability front and center.
Judge Signals He Could Rule to Halt Sales of Common Abortion Pill
A U.S. District Court case is being widely followed because the judge鈥檚 decision could overturn the FDA鈥檚 approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
